STERIS (STE) 10-Q2025 Q2 Quarterly report

Filed: 7 Nov 24, 7:53am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: accelerator, agent, agreed, air, alleged, allegedly, ambient, America, anniversary, approach, attained, attention, Bank, bear, benchmark, biopharmaceutical, breakage, cancer, cap, caption, Chase, classification, compensatory, constant, country, County, criteria, criterion, customary, defending, defense, diagnosed, digit, disease, disposal, divert, divestiture, domicile, drove, EO, ethylene, event, Fewer, frequently, geography, globe, inception, indemnification, indemnity, JPMorgan, Lake, lease, lender, lengthy, met, network, nonforfeitable, oxide, payable, payroll, portfolio, premium, Prepaid, prepayment, proximity, punitive, pursuing, recipient, relevant, removing, repayable, reside, rounding, science, shift, softening, structured, sued, swing, swingline, targeted, thereon, timeline, trial, unpaid, vigorously

Removed: American, Animal, authorization, awarded, biopharma, buying, Canada, Cantel, common, consistently, Delayed, destocking, earlier, easing, eligibility, evaluating, exceeded, expire, favorably, finance, fluctuation, holder, hospital, inflationary, Italia, linen, Loan, mandating, Mexican, pandemic, replace, rollforward, scrutiny, Servizi, supplier, utilize, vaccine, validate, validation, washing

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated STE transcripts

STE similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification Pursuant to § 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, in connection with the filing of the Form 10-Q of STERIS plc (the “Company”) for the quarter ended September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies, that, to such officer's knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.


						/s/ DANIEL A. CARESTIO
Name:						Daniel A. Carestio
Title:						President and Chief Executive Officer

						/s/ MICHAEL J. TOKICH
Name:						Michael J. Tokich
Title:						Senior Vice President and Chief Financial Officer

Dated: November 7, 2024